vac∆6
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started May 18, 2019 (NCT05762523)
Timeline
Indications
Mechanism of action
- OrthopoxvirusImmunity, active
Orthopoxvirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05846243 | Phase 2/Phase 3 (Phase 3) | Oct 1, 2021 | Government of Russia |
| NCT05762523 | Phase 1 | May 18, 2019 | Government of Russia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 2 | 2 | 2 | 2019 |
1 organizations
Page 1 / 1